Yuguang Song

发表

Immune correlates of clinical benefit in a phase I study of hyperthermia with adoptive T cell immunotherapy in patients with solid tumors

Yanjie Zhao, H. Lyerly, J. Zhao, 2019, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

Enhanced antitumor effects and improved immune status of dendritic cell and cytokine-induced killer cell infusion in advanced cancer patients.

Yanjie Zhao, Lei Zhou, Jun Ren, 2017, Molecular and clinical oncology.

Restored CD8+PD-1+ T Cells Facilitate the Response to Anti-PD-1 for Patients With Pancreatic Ductal Adenocarcinoma

Jing Zhao, Yufeng Yuan, G. Qiao, 2021, Frontiers in Oncology.

DC-CIK Infusions Restore CD8+Immunity, Physical Activity and Improve Clinical Efficacy in Advanced Cancer Patients

H. Lyerly, Lei Zhou, Jun Ren, 2015 .

Autologous Dendritic Cell-Cytokine Induced Killer Cell Immunotherapy Combined with S-1 Plus Cisplatin in Patients with Advanced Gastric Cancer: A Prospective Study

X. Yi, H. Lyerly, M. Morse, 2018, Clinical Cancer Research.

Continuous DC-CIK infusions restore CD8+ cellular immunity, physical activity and improve clinical efficacy in advanced cancer patients unresponsive to conventional treatments.

H. Lyerly, Lei Zhou, Jun Ren, 2015, Asian Pacific journal of cancer prevention : APJCP.

Infiltration of metastatic lymph nodes with PD-1+ T cells is associated with improved disease-free and overall survival in resected N+ NSCLC.

H. Lyerly, M. Morse, Jun Ren, 2020, American journal of cancer research.

AutologousDendritic Cell-Cytokine InducedKiller Cell Immunotherapy Combined with S-1 Plus Cisplatin in Patients with Advanced Gastric Cancer : A Prospective Study

X. Yi, H. Lyerly, M. Morse, 2019 .

Serial assessment of circulating T lymphocyte phenotype and receptor repertoire during treatment of non-muscle invasive bladder cancer with adoptive T cell immunotherapy.

Yanjie Zhao, H. Lyerly, M. Morse, 2020, American journal of cancer research.

Dendritic Cell/Cytokine-Induced Killer Cell Immunotherapy Combined with S-1 in Patients with Advanced Pancreatic Cancer: A Prospective Study

X. Yi, Yanjie Zhao, H. Lyerly, 2017, Clinical Cancer Research.

ERBB2D16 Expression in HER2 Positive Gastric Cancer Is Associated With Resistance to Trastuzumab

Jing Zhao, Hongyan Huang, G. Qiao, 2022, Frontiers in Oncology.

Establishment of a prospective multicenter cohort for advanced non‐small cell lung cancer in China (CAPTRA‐Lung study)

Li Zhang, Junling Li, Shucai Zhang, 2018, Thoracic cancer.

Matrix metalloproteinase-9 silencing by RNA interference promotes the adhesive-invasive switch in HT1080 human fibrosarcoma cells.

W. Shi, Hongmei Zhang, G. An, 2012, Clinical laboratory.

[Dynamic Changes of Circulating Tumor DNA in Peripheral Blood Predict the Efficacy of TKI in the Treatment of Lung Adenocarcinoma with EGFR Mutation].

Yanjie Zhao, J. Zhao, Jun Ren, 2019, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

Expansion of CD3+CD8+PD1+ T lymphocytes and TCR repertoire diversity predict clinical responses to adoptive cell therapy in advanced gastric cancer.

G. Qiao, Qian Zhu, Yuze Zhao, 2022, American journal of cancer research.

Prospective randomized comparative study on rivaroxaban and LMWH for prophylaxis of post-apheresis thrombosis in adoptive T cell immunotherapy cancer patients

Yanjie Zhao, H. Lyerly, M. Morse, 2019, Journal of Thrombosis and Thrombolysis.

Combined oral low-dose cyclophosphamide endocrine therapy may improve clinical response among patients with metastatic breast cancer via Tregs in TLSs

Shuo Wang, Yuguang Song, Dongwen Rong, 2024, Scientific reports.

Combination of DC/CIK adoptive T cell immunotherapy with chemotherapy in advanced non-small-cell lung cancer (NSCLC) patients: a prospective patients’ preference-based study (PPPS)

X. Zhou, X. Wang, H. Lyerly, 2018, Clinical and Translational Oncology.